Q&A

Reducing Bacterial Adhesion And Biofouling On Medical Device Surfaces: An Interview With Jeannette Ho

The Endexo® surface modification technology has been extensively studied and commercially used for improving the blood compatibility of medical devices to reduce thrombosis risk. However, its potential to reduce bacterial adhesion of multiple bacterial species, and overall biofouling on device surfaces, is only now starting to be recognized. This interview with Jeannette Ho, the Head of Surface Modification at Evonik, discusses opportunities for medical device companies to leverage this passive, stable and durable technology platform to reduce bacterial adhesion and biofouling.

VIEW THE Q&A!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Med Device Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: